SynthesisBMC nephrology2026

Efficacy and safety of BAFF/APRIL-pathway inhibitors versus placebo in adults with IgA nephropathy: a systematic review with pairwise and network meta-analysis.

Nada Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.